Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases
We studied 28 cases of lymphoepithelioma-like carcinoma of the bladder, one case in the renal pelvis, and one in the urethra. The mean age of the patients was 67.6 years with 21 (70%) males. Seventeen cases (56.7%) were pure with the remaining mixed with other patterns of carcinoma, including invasi...
Gespeichert in:
| Veröffentlicht in: | Modern pathology 2007-08, Vol.20 (8), p.828-834 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 834 |
|---|---|
| container_issue | 8 |
| container_start_page | 828 |
| container_title | Modern pathology |
| container_volume | 20 |
| creator | Tamas, Ecaterina F Nielsen, Matthew E Schoenberg, Mark P Epstein, Jonathan I |
| description | We studied 28 cases of lymphoepithelioma-like carcinoma of the bladder, one case in the renal pelvis, and one in the urethra. The mean age of the patients was 67.6 years with 21 (70%) males. Seventeen cases (56.7%) were pure with the remaining mixed with other patterns of carcinoma, including invasive urothelial carcinoma (
n
=10), invasive adenocarcinoma (
n
=3), and squamous cell carcinoma (
n
=2). The surface demonstrated carcinoma
in situ
(CIS) in six cases, noninvasive high-grade papillary urothelial carcinoma in three cases, and
in situ
adenocarcinoma in one case. In 19/30 (66%) cases, there was a heavy lymphocytic infiltrate and in the remaining 11/30 (34%) cases a mixed inflammatory infiltrate. None of the 26 cases labeled for EBV-encoded RNA by
in situ
hybridization. Tumor stages at presentation were: seven cases T1 (23%); 14 cases T2 (47%); seven cases T3 (23%); and two cases T4 (7%). Treatment consisted of radical cystectomy in 13/30 cases (43%); partial cystectomy in 4/30 cases (13%); nephrectomy in one case (3%), and transurethral resection often followed by radiation or chemotherapy in 12/30 (40%) cases. The mean follow up for patients without progression was 31 months. Eight of 27 cases with follow-up (30%) cases had tumor recurrence, with seven patients having metastases. In cases treated with cystectomy, the 5-year actuarial recurrence-free risk was 59% (62 and 57%, for pure and mixed cases, respectively). Lymphoepithelioma-like carcinoma, whether in pure or mixed form, has a similar prognosis to ordinary urothelial carcinoma when treated by cystectomy. Of the three pure cases treated by chemotherapy, two were free of disease at 4 and 65 months and the third had recurrent disease at 17 months. Given the association of lymphoepithelioma-like carcinoma with urothelial carcinoma in 47% of our cases and its propensity for multifocality, partial cystectomy would typically be ill advised for lymphoepithelioma-like carcinoma. |
| doi_str_mv | 10.1038/modpathol.3800823 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70743641</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70743641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-ceed190b1ad3d7a0cef85a68ae2044dbb15bb7e218447a407af3045052c6597c3</originalsourceid><addsrcrecordid>eNp9kU9P3DAQxS1UVLbAB-DQyuqht9Dxv7W3twq1gLQSF3qOHHvCmiZxaidS99vXKFuQOHCyRvN7z6P3CLlgcMlAmK999KOddrG7FAbAcHFEVkwJqIAb9Y6swGxEJTaKn5APOT8CMKkMf09OmFaSSclXpN_u-3EXcQzTDrsQe1t14TdSZ5MLQxlpbGlZ0TmFwaY9nZJ10zdqqevCEFxcDogPwdmO5mn2-yeFADrOCakdPO3DX_TFMGM-I8et7TKeH95T8uvnj_urm2p7d3179X1bOan0VDlEzzbQMOuF1xYctkbZtbHIQUrfNEw1jUbOjJTaStC2FSAVKO7WaqOdOCVfFt8xxT8z5qnuQ3bYdXbAOOdag5ZiLVkBP78CH-OchnJbzTljSmsFBWIL5FLMOWFbjyn0JYyaQf1URP1cRH0oomg-HYznpkf_ojgkXwC-ALmshgdMLz-_5fpxEQ12KvE-u_7f_wNKG6IR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221157750</pqid></control><display><type>article</type><title>Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Tamas, Ecaterina F ; Nielsen, Matthew E ; Schoenberg, Mark P ; Epstein, Jonathan I</creator><creatorcontrib>Tamas, Ecaterina F ; Nielsen, Matthew E ; Schoenberg, Mark P ; Epstein, Jonathan I</creatorcontrib><description>We studied 28 cases of lymphoepithelioma-like carcinoma of the bladder, one case in the renal pelvis, and one in the urethra. The mean age of the patients was 67.6 years with 21 (70%) males. Seventeen cases (56.7%) were pure with the remaining mixed with other patterns of carcinoma, including invasive urothelial carcinoma (
n
=10), invasive adenocarcinoma (
n
=3), and squamous cell carcinoma (
n
=2). The surface demonstrated carcinoma
in situ
(CIS) in six cases, noninvasive high-grade papillary urothelial carcinoma in three cases, and
in situ
adenocarcinoma in one case. In 19/30 (66%) cases, there was a heavy lymphocytic infiltrate and in the remaining 11/30 (34%) cases a mixed inflammatory infiltrate. None of the 26 cases labeled for EBV-encoded RNA by
in situ
hybridization. Tumor stages at presentation were: seven cases T1 (23%); 14 cases T2 (47%); seven cases T3 (23%); and two cases T4 (7%). Treatment consisted of radical cystectomy in 13/30 cases (43%); partial cystectomy in 4/30 cases (13%); nephrectomy in one case (3%), and transurethral resection often followed by radiation or chemotherapy in 12/30 (40%) cases. The mean follow up for patients without progression was 31 months. Eight of 27 cases with follow-up (30%) cases had tumor recurrence, with seven patients having metastases. In cases treated with cystectomy, the 5-year actuarial recurrence-free risk was 59% (62 and 57%, for pure and mixed cases, respectively). Lymphoepithelioma-like carcinoma, whether in pure or mixed form, has a similar prognosis to ordinary urothelial carcinoma when treated by cystectomy. Of the three pure cases treated by chemotherapy, two were free of disease at 4 and 65 months and the third had recurrent disease at 17 months. Given the association of lymphoepithelioma-like carcinoma with urothelial carcinoma in 47% of our cases and its propensity for multifocality, partial cystectomy would typically be ill advised for lymphoepithelioma-like carcinoma.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1038/modpathol.3800823</identifier><identifier>PMID: 17541442</identifier><identifier>CODEN: MODPEO</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Adenocarcinoma - pathology ; Aged ; Aged, 80 and over ; Bladder ; Cancer ; Carcinoma - pathology ; Carcinoma - therapy ; Carcinoma in Situ - pathology ; Carcinoma, Squamous Cell - pathology ; Cell Differentiation ; Chemotherapy ; Cytokeratin ; Disease-Free Survival ; Epithelial Cells - pathology ; Female ; Follow-Up Studies ; Humans ; Hybridization ; Laboratory Medicine ; Lymphocytes ; Lymphocytes - pathology ; Male ; Medical prognosis ; Medicine ; Medicine & Public Health ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Staging ; original-article ; Pathology ; Time Factors ; Treatment Outcome ; Urogenital system ; Urologic Neoplasms - pathology ; Urologic Neoplasms - therapy ; Urological surgery</subject><ispartof>Modern pathology, 2007-08, Vol.20 (8), p.828-834</ispartof><rights>United States and Canadian Academy of Pathology, Inc. 2007</rights><rights>Copyright Nature Publishing Group Aug 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-ceed190b1ad3d7a0cef85a68ae2044dbb15bb7e218447a407af3045052c6597c3</citedby><cites>FETCH-LOGICAL-c457t-ceed190b1ad3d7a0cef85a68ae2044dbb15bb7e218447a407af3045052c6597c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/221157750?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17541442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tamas, Ecaterina F</creatorcontrib><creatorcontrib>Nielsen, Matthew E</creatorcontrib><creatorcontrib>Schoenberg, Mark P</creatorcontrib><creatorcontrib>Epstein, Jonathan I</creatorcontrib><title>Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>We studied 28 cases of lymphoepithelioma-like carcinoma of the bladder, one case in the renal pelvis, and one in the urethra. The mean age of the patients was 67.6 years with 21 (70%) males. Seventeen cases (56.7%) were pure with the remaining mixed with other patterns of carcinoma, including invasive urothelial carcinoma (
n
=10), invasive adenocarcinoma (
n
=3), and squamous cell carcinoma (
n
=2). The surface demonstrated carcinoma
in situ
(CIS) in six cases, noninvasive high-grade papillary urothelial carcinoma in three cases, and
in situ
adenocarcinoma in one case. In 19/30 (66%) cases, there was a heavy lymphocytic infiltrate and in the remaining 11/30 (34%) cases a mixed inflammatory infiltrate. None of the 26 cases labeled for EBV-encoded RNA by
in situ
hybridization. Tumor stages at presentation were: seven cases T1 (23%); 14 cases T2 (47%); seven cases T3 (23%); and two cases T4 (7%). Treatment consisted of radical cystectomy in 13/30 cases (43%); partial cystectomy in 4/30 cases (13%); nephrectomy in one case (3%), and transurethral resection often followed by radiation or chemotherapy in 12/30 (40%) cases. The mean follow up for patients without progression was 31 months. Eight of 27 cases with follow-up (30%) cases had tumor recurrence, with seven patients having metastases. In cases treated with cystectomy, the 5-year actuarial recurrence-free risk was 59% (62 and 57%, for pure and mixed cases, respectively). Lymphoepithelioma-like carcinoma, whether in pure or mixed form, has a similar prognosis to ordinary urothelial carcinoma when treated by cystectomy. Of the three pure cases treated by chemotherapy, two were free of disease at 4 and 65 months and the third had recurrent disease at 17 months. Given the association of lymphoepithelioma-like carcinoma with urothelial carcinoma in 47% of our cases and its propensity for multifocality, partial cystectomy would typically be ill advised for lymphoepithelioma-like carcinoma.</description><subject>Adenocarcinoma - pathology</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bladder</subject><subject>Cancer</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - therapy</subject><subject>Carcinoma in Situ - pathology</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Cell Differentiation</subject><subject>Chemotherapy</subject><subject>Cytokeratin</subject><subject>Disease-Free Survival</subject><subject>Epithelial Cells - pathology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hybridization</subject><subject>Laboratory Medicine</subject><subject>Lymphocytes</subject><subject>Lymphocytes - pathology</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Staging</subject><subject>original-article</subject><subject>Pathology</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Urogenital system</subject><subject>Urologic Neoplasms - pathology</subject><subject>Urologic Neoplasms - therapy</subject><subject>Urological surgery</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU9P3DAQxS1UVLbAB-DQyuqht9Dxv7W3twq1gLQSF3qOHHvCmiZxaidS99vXKFuQOHCyRvN7z6P3CLlgcMlAmK999KOddrG7FAbAcHFEVkwJqIAb9Y6swGxEJTaKn5APOT8CMKkMf09OmFaSSclXpN_u-3EXcQzTDrsQe1t14TdSZ5MLQxlpbGlZ0TmFwaY9nZJ10zdqqevCEFxcDogPwdmO5mn2-yeFADrOCakdPO3DX_TFMGM-I8et7TKeH95T8uvnj_urm2p7d3179X1bOan0VDlEzzbQMOuF1xYctkbZtbHIQUrfNEw1jUbOjJTaStC2FSAVKO7WaqOdOCVfFt8xxT8z5qnuQ3bYdXbAOOdag5ZiLVkBP78CH-OchnJbzTljSmsFBWIL5FLMOWFbjyn0JYyaQf1URP1cRH0oomg-HYznpkf_ojgkXwC-ALmshgdMLz-_5fpxEQ12KvE-u_7f_wNKG6IR</recordid><startdate>20070801</startdate><enddate>20070801</enddate><creator>Tamas, Ecaterina F</creator><creator>Nielsen, Matthew E</creator><creator>Schoenberg, Mark P</creator><creator>Epstein, Jonathan I</creator><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20070801</creationdate><title>Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases</title><author>Tamas, Ecaterina F ; Nielsen, Matthew E ; Schoenberg, Mark P ; Epstein, Jonathan I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-ceed190b1ad3d7a0cef85a68ae2044dbb15bb7e218447a407af3045052c6597c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bladder</topic><topic>Cancer</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - therapy</topic><topic>Carcinoma in Situ - pathology</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Cell Differentiation</topic><topic>Chemotherapy</topic><topic>Cytokeratin</topic><topic>Disease-Free Survival</topic><topic>Epithelial Cells - pathology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hybridization</topic><topic>Laboratory Medicine</topic><topic>Lymphocytes</topic><topic>Lymphocytes - pathology</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Staging</topic><topic>original-article</topic><topic>Pathology</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Urogenital system</topic><topic>Urologic Neoplasms - pathology</topic><topic>Urologic Neoplasms - therapy</topic><topic>Urological surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tamas, Ecaterina F</creatorcontrib><creatorcontrib>Nielsen, Matthew E</creatorcontrib><creatorcontrib>Schoenberg, Mark P</creatorcontrib><creatorcontrib>Epstein, Jonathan I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tamas, Ecaterina F</au><au>Nielsen, Matthew E</au><au>Schoenberg, Mark P</au><au>Epstein, Jonathan I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2007-08-01</date><risdate>2007</risdate><volume>20</volume><issue>8</issue><spage>828</spage><epage>834</epage><pages>828-834</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><coden>MODPEO</coden><abstract>We studied 28 cases of lymphoepithelioma-like carcinoma of the bladder, one case in the renal pelvis, and one in the urethra. The mean age of the patients was 67.6 years with 21 (70%) males. Seventeen cases (56.7%) were pure with the remaining mixed with other patterns of carcinoma, including invasive urothelial carcinoma (
n
=10), invasive adenocarcinoma (
n
=3), and squamous cell carcinoma (
n
=2). The surface demonstrated carcinoma
in situ
(CIS) in six cases, noninvasive high-grade papillary urothelial carcinoma in three cases, and
in situ
adenocarcinoma in one case. In 19/30 (66%) cases, there was a heavy lymphocytic infiltrate and in the remaining 11/30 (34%) cases a mixed inflammatory infiltrate. None of the 26 cases labeled for EBV-encoded RNA by
in situ
hybridization. Tumor stages at presentation were: seven cases T1 (23%); 14 cases T2 (47%); seven cases T3 (23%); and two cases T4 (7%). Treatment consisted of radical cystectomy in 13/30 cases (43%); partial cystectomy in 4/30 cases (13%); nephrectomy in one case (3%), and transurethral resection often followed by radiation or chemotherapy in 12/30 (40%) cases. The mean follow up for patients without progression was 31 months. Eight of 27 cases with follow-up (30%) cases had tumor recurrence, with seven patients having metastases. In cases treated with cystectomy, the 5-year actuarial recurrence-free risk was 59% (62 and 57%, for pure and mixed cases, respectively). Lymphoepithelioma-like carcinoma, whether in pure or mixed form, has a similar prognosis to ordinary urothelial carcinoma when treated by cystectomy. Of the three pure cases treated by chemotherapy, two were free of disease at 4 and 65 months and the third had recurrent disease at 17 months. Given the association of lymphoepithelioma-like carcinoma with urothelial carcinoma in 47% of our cases and its propensity for multifocality, partial cystectomy would typically be ill advised for lymphoepithelioma-like carcinoma.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>17541442</pmid><doi>10.1038/modpathol.3800823</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0893-3952 |
| ispartof | Modern pathology, 2007-08, Vol.20 (8), p.828-834 |
| issn | 0893-3952 1530-0285 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70743641 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection |
| subjects | Adenocarcinoma - pathology Aged Aged, 80 and over Bladder Cancer Carcinoma - pathology Carcinoma - therapy Carcinoma in Situ - pathology Carcinoma, Squamous Cell - pathology Cell Differentiation Chemotherapy Cytokeratin Disease-Free Survival Epithelial Cells - pathology Female Follow-Up Studies Humans Hybridization Laboratory Medicine Lymphocytes Lymphocytes - pathology Male Medical prognosis Medicine Medicine & Public Health Middle Aged Neoplasm Invasiveness Neoplasm Staging original-article Pathology Time Factors Treatment Outcome Urogenital system Urologic Neoplasms - pathology Urologic Neoplasms - therapy Urological surgery |
| title | Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A03%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lymphoepithelioma-like%20carcinoma%20of%20the%20urinary%20tract:%20a%20clinicopathological%20study%20of%2030%20pure%20and%20mixed%20cases&rft.jtitle=Modern%20pathology&rft.au=Tamas,%20Ecaterina%20F&rft.date=2007-08-01&rft.volume=20&rft.issue=8&rft.spage=828&rft.epage=834&rft.pages=828-834&rft.issn=0893-3952&rft.eissn=1530-0285&rft.coden=MODPEO&rft_id=info:doi/10.1038/modpathol.3800823&rft_dat=%3Cproquest_cross%3E70743641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221157750&rft_id=info:pmid/17541442&rfr_iscdi=true |